Thailand’s billion-dollar bid to become a pharmaceutical powerhouse is hitting turbulence – swelling patent backlogs, looming price caps and tougher regulations are unnerving investors and jeopardizing the industry’s long-term prospects
Thailand’s billion-dollar bid to become a pharmaceutical powerhouse is hitting turbulence – swelling patent backlogs, looming price caps and tougher regulations are unnerving investors and jeopardizing the industry’s long-term prospects